EzriCare and Delsam Artificial Tears Recall

Global Pharma Healthcare issued a February 2023 recall for EzriCare Artificial Tears, Delsam Pharma Artificial Tears and Delsam Pharma Artificial Eye Ointment because of potential bacterial contamination. The CDC reported some people lost their vision and four people died.

Last Modified: May 6, 2024
Fact Checked

Editors carefully fact-check all Drugwatch.com content for accuracy and quality.

Drugwatch.com has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Why Trust DrugWatch?

Drugwatch.com has been empowering patients for more than a decade

Drugwatch.com has provided reliable, trusted information about medications, medical devices and general health since 2008. We’ve also connected thousands of people injured by drugs and medical devices with top-ranked national law firms to take action against negligent corporations.

Our team includes experienced medical writers, award-winning journalists, researchers and certified medical and legal experts. Drugwatch.com is HONCode (Health On the Net Foundation) certified. This means the high-quality information we provide comes from credible sources, such as peer-reviewed medical journals and expert interviews.

The information on Drugwatch.com has been medically and legally reviewed by more than 30 expert contributors, including doctors, pharmacists, lawyers, patient advocates and other health care professionals. Our writers are members of professional associations, including American Medical Writers Association, American Bar Association, The Alliance of Professional Health Advocates and International Society for Medical Publication Professionals.

About Drugwatch.com

  • Assisting patients and their families since 2008.
  • Helped more than 12,000 people find legal help.
  • A+ rating from the Better Business Bureau.
  • 5-star reviewed medical and legal information site.
Learn More About Us


"Drugwatch opened my eyes to the realities of big pharmacy. Having a family member with major depression and anxiety, I was looking for information on her medications. I found information that was very helpful, that her psychiatrist never told her."
Marianne Zahren Patient’s Family Member
  • Google Business Rating
  • BBB A+ Rating Logo

Which EzriCare and Delsam Eye Drops Were Recalled?

On Feb. 2, 2023, Global Pharma Healthcare recalled EzriCare Artificial Tears and Delsam Pharma Artificial Tears. These EzriCare eye drops were sold online, mainly through Walmart or Amazon. At one point, EzriCare Artificial Tears were one of the top 10 products sold on Amazon for dry eye relief, according to CBS News.

Global Pharma’s Recalled Eye Drops include:
  • EzriCare Artificial Tears Lubricant Eye Drops (carboxymethylcellulose sodium) 10 mg in 1 mL, ½ fl. oz. (15 ml) bottle. NDC 79503-0101-15, UPC 3 79503 10115 7
  • Delsam Pharma Artificial Tears and Lubricant Eye Drops (carboxymethylcellulose sodium) 10 mg in 1 mL, ½ fl. oz. (15 ml) bottle. NDC 72570-121-15, UPC 3 72570 12115 8

On Feb. 24, 2023, Global Healthcare also recalled its Delsam Pharma Artificial Eye Ointment (mineral oil 15%, white petrolatum 83%, 3.5 grams / 1/8 oz.). The recalled batch number is H29, NDC 72570-122-35, UPC 3 72570 12235 3.

The Centers for Disease Control and Prevention and the U.S. Food and Drug Administration have warned people to stop using these products because of the risk of serious eye infections.

Why Were EzriCare Artificial Tears Recalled?

Global Pharma Healthcare recalled EzriCare Artificial Tears Lubricant Eye Drops because the CDC and FDA have linked the product to a multistate outbreak of infections caused by Pseudomonas aeruginosa bacterium.

Attorney Trent Miracle explains what led to the EzriCare and Delsam Pharma Artificial Tears recall.

The eye drop manufacturer also recalled Delsam Pharma Artificial Tears and Delsam Pharma Artificial Eye Ointment after the FDA recommended the recall for potential microbial contamination. In addition, eye ointment packages were leaking and could be otherwise compromised.

“Thus far we have not determined whether our manufacturing facility is the source of the contamination. Nevertheless, out of an abundance of caution, we are recalling the products at issue,” Global Pharma told CBS News.

According to the latest May 2023 EzriCare eye drop recall update from the CDC, 81 patients in 18 states have been infected by a bacterium called Verona Integron-mediated Metallo-β-lactamase (VIM) and Guiana-Extended Spectrum-β-Lactamase (GES)-producing carbapenem-resistant Pseudomonas aeruginosa (VIM-GES-CRPA)

Risks of EzriCare Artificial Tears

The biggest risk of using EzriCare Artificial Tears is becoming infected with VIM-GES-CRPA. When the CDC tested opened bottles of EzriCare Artificial Tears, the products tested positive for VIM-GES-CRPA.

This is a very rare strain of Pseudomonas aeruginosa that hasn’t been seen in the U.S. before. It led to eye infections that caused vision loss in 14 people and four deaths, according to the CDC’s May 15, 2023, update. The infection can also spread past the eye and into other parts of the body.

Other EzriCare Artificial Tears side effects not related to infections include eye pain, blurry vision and allergic reactions.

FDA Response to Artificial Tears Recall

In partnership with the CDC, the FDA continues to investigate the bacterial outbreak linked to EzriCare Artificial Tears. The agencies are working together to test unopened bottles of EzriCare eye drops to see if the products were contaminated during manufacturing. As of March 21, 2023, there have been no updates on testing results. In the meantime, the FDA has warned people not to use recalled products.

Global Pharma Healthcare didn’t comply with current good marketing practices, or CGMP, according to the FDA. The eye drop maker didn’t properly test for bacteria, didn’t use an adequate preservative and didn’t have good manufacturing controls for tamper-evident packaging.

The agency has since placed Global Pharma on import alert. The import alert prevents the India-based manufacturer’s products from entering the U.S.

What Should I Do If I Used Recalled EzriCare Artificial Tears?

If you used recalled EzriCare Artificial Tears, stop using the product right away. The CDC doesn’t recommend bacterial testing for people with no symptoms. So, if you don’t have any symptoms of infection, you don’t have to take action.

But people who used EzriCare or Delsam Pharma Artificial Tears and have infection symptoms should contact their medical providers and seek medical care right away, according to the CDC.

Symptoms of an eye infection from contaminated EzriCare Artificial Tears include:
  • Blurry vision
  • Discharge from the eye that’s yellow, green or clear
  • Eye or eyelid redness
  • Eye pain or discomfort
  • Feeling that there is something in your eye (foreign body sensation)
  • Increased light sensitivity

Can I File an EzriCare Lawsuit?

If you or a loved one suffered an eye infection or vision loss after using EzriCare or Delsam Pharma Artificial Tears, you may be able to file an EzriCare or Delsam lawsuit for compensation. After the recall, people began filing injury lawsuits against Global Pharma, EzriCare, Aru Pharma, Walmart and others.

Carolyn Ward sued EzriCare, Aru Pharma and Walmart after she suffered an eye infection. Even after she underwent antibiotic and steroid treatments, the infection spread to her torso, back and abdomen.

Please seek the advice of a medical professional before making health care decisions.